Molecular cloning of canine Wilms’ tumor 1 for immunohistochemical analysis in canine tissues

Wilms’ tumor 1 (WT1) expression has been investigated in various human cancers as a target molecule for cancer immunotherapy. However, few studies have focused on WT1 expression in dogs. Firstly, cDNA of canine WT1 (cWT1) was molecularly cloned from normal canine kidney. The cross-reactivity of the...

Descripción completa

Detalles Bibliográficos
Autores principales: SAKAI, Osamu, SAKURAI, Masashi, SAKAI, Hiroki, KUBO, Masahito, HIRAOKA, Hiroko, BABA, Kenji, OKUDA, Masaru, MIZUNO, Takuya
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Japanese Society of Veterinary Science 2017
Materias:
Clinical Pathology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5559376/
https://www.ncbi.nlm.nih.gov/pubmed/28603218
http://dx.doi.org/10.1292/jvms.17-0229
Descripción
Sumario:Wilms’ tumor 1 (WT1) expression has been investigated in various human cancers as a target molecule for cancer immunotherapy. However, few studies have focused on WT1 expression in dogs. Firstly, cDNA of canine WT1 (cWT1) was molecularly cloned from normal canine kidney. The cross-reactivity of the anti-human WT1 monoclonal antibody (6F-H2) with cWT1 was confirmed via Western blotting using cells overexpressing cWT1. Immunohistochemical staining revealed that cWT1 expression was detected in all canine lymphoma tissues and in some normal canine tissues, including the kidney and lymph node. cWT1 is a potential immunotherapy target against canine cancers.

Ejemplares similares